Published as a Resource article in the open access journal Cell Reports*, results from an international study co-led by investigators…
featured news
Published in The Lancet, results of the randomized phase III BEATcc academic trial (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030) show that adding immune checkpoint…
VHIO consolidates its advanced therapy programme to develop new innovative treatments against cancer
The 1st VHIO-BBVA Foundation International Symposium on Cell-based Therapies in Oncology , organised by Dr. Alena Gros, head of the…
Vall d’Hebron Barcelona Hospital Campus has celebrated its first PhD Day, a whole day of scientific activities created for and…
Biliary tract cancer (BTC) poses a distinctive challenge in oncology, mainly due to diagnosis at late-stage and limited effective systemic…
Clarivate, a global leader in connecting people and organizations to intelligence to transform the world, has revealed its list of…
Approximately 10% of patients with metastatic castration-resistant prostate cancer have alterations in the BRCA1 or BRCA2 genes which are associated…
The biotech company Peptomyc SL announced today that it has been awarded €5 million blended financing from the Horizon Europe,…
The kick-off meeting of PragmaTIL, a project that will finance a pioneering academic clinical trial in advanced therapies, coordinated by…
The Breast Cancer Research Foundation (BCRF) will commit $60.2 million to breast cancer research in 2023-2024, supporting more than 250…
